These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7694545)

  • 1. Resistance of Pseudomonas pseudomallei growing as a biofilm on silastic discs to ceftazidime and co-trimoxazole.
    Vorachit M; Lam K; Jayanetra P; Costerton JW
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2000-2. PubMed ID: 7694545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of amoxicillin-clavulanate, doxycycline, ceftazidime, imipenem, and trimethoprim-sulfamethoxazole against biofilm of Brazilian strains of Burkholderia pseudomallei.
    Bandeira Tde J; Moreira CA; Brilhante RS; Castelo-Branco Dde S; Neto MP; Cordeiro Rde A; Rodrigues Tde J; Rocha MF; Sidrim JJ
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5771-3. PubMed ID: 24002089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis.
    Castelo-Branco DS; Riello GB; Vasconcelos DC; Guedes GM; Serpa R; Bandeira TJ; Monteiro AJ; Cordeiro RA; Rocha MF; Sidrim JJ; Brilhante RS
    J Appl Microbiol; 2016 Mar; 120(3):600-6. PubMed ID: 26669506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion and activity of antibiotics against Burkholderia pseudomallei biofilms.
    Pibalpakdee P; Wongratanacheewin S; Taweechaisupapong S; Niumsup PR
    Int J Antimicrob Agents; 2012 Apr; 39(4):356-9. PubMed ID: 22364716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Resistance to Folate Pathway Inhibitors in
    Podnecky NL; Rhodes KA; Mima T; Drew HR; Chirakul S; Wuthiekanun V; Schupp JM; Sarovich DS; Currie BJ; Keim P; Schweizer HP
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological cut-off value of clinical isolates of Burkholderia pseudomallei from Northern Queensland to meropenem, ceftazidime, trimethoprim/sulfamethoxazole and doxycycline by the microbroth dilution method.
    Maloney S; Engler C; Norton R
    J Glob Antimicrob Resist; 2017 Sep; 10():291-294. PubMed ID: 28729203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei.
    Dance DA; Davong V; Soeng S; Phetsouvanh R; Newton PN; Turner P
    Int J Antimicrob Agents; 2014 Oct; 44(4):368-9. PubMed ID: 25245211
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of antibiotic susceptibility testing methods for cotrimoxazole with Burkholderia pseudomallei.
    Piliouras P; Ulett GC; Ashhurst-Smith C; Hirst RG; Norton RE
    Int J Antimicrob Agents; 2002 May; 19(5):427-9. PubMed ID: 12007851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofilm formation by Stenotrophomonas maltophilia: modulation by quinolones, trimethoprim-sulfamethoxazole, and ceftazidime.
    Di Bonaventura G; Spedicato I; D'Antonio D; Robuffo I; Piccolomini R
    Antimicrob Agents Chemother; 2004 Jan; 48(1):151-60. PubMed ID: 14693533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growing Burkholderia pseudomallei in biofilm stimulating conditions significantly induces antimicrobial resistance.
    Sawasdidoln C; Taweechaisupapong S; Sermswan RW; Tattawasart U; Tungpradabkul S; Wongratanacheewin S
    PLoS One; 2010 Feb; 5(2):e9196. PubMed ID: 20169199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of nutritional stress on drug susceptibility and biofilm structures of Burkholderia pseudomallei and Burkholderia thailandensis grown in static and microfluidic systems.
    Anutrakunchai C; Bolscher JGM; Krom BP; Kanthawong S; Chareonsudjai S; Taweechaisupapong S
    PLoS One; 2018; 13(3):e0194946. PubMed ID: 29579106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-LL-31 in combination with ceftazidime synergistically enhances bactericidal activity and biofilm destruction in
    Wongkaewkhiaw S; Taweechaisupapong S; Anutrakunchai C; Nazmi K; Bolscher JGM; Wongratanacheewin S; Kanthawong S
    Biofouling; 2019 May; 35(5):573-584. PubMed ID: 31282211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burkholderia pseudomallei resistance to antibiotics in biofilm-induced conditions is related to efflux pumps.
    Sirijant N; Sermswan RW; Wongratanacheewin S
    J Med Microbiol; 2016 Nov; 65(11):1296-1306. PubMed ID: 27702426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The BpeEF-OprC efflux pump is responsible for widespread trimethoprim resistance in clinical and environmental Burkholderia pseudomallei isolates.
    Podnecky NL; Wuthiekanun V; Peacock SJ; Schweizer HP
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4381-6. PubMed ID: 23817379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei.
    Dance DA; Wuthiekanun V; Chaowagul W; Suputtamongkol Y; White NJ
    J Antimicrob Chemother; 1991 Aug; 28(2):321-4. PubMed ID: 1723404
    [No Abstract]   [Full Text] [Related]  

  • 16. Rhamnolipid enhances
    Sidrim JJ; Ocadaque CJ; Amando BR; de M Guedes GM; Costa CL; Brilhante RS; A Cordeiro R; Rocha MF; Scm Castelo-Branco D
    Future Microbiol; 2020 Aug; 15():1109-1121. PubMed ID: 32954847
    [No Abstract]   [Full Text] [Related]  

  • 17. In-vitro activity of β-lactams/trimethoprim-sulfamethoxazole combinations against different strains of Burkholderia pseudomallei.
    Mohamad NI; Harun A; Hasan H; Deris ZZ
    Trop Biomed; 2022 Mar; 39(1):11-16. PubMed ID: 35225295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
    Crowe A; McMahon N; Currie BJ; Baird RW
    Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand.
    Saiprom N; Amornchai P; Wuthiekanun V; Day NP; Limmathurotsakul D; Peacock SJ; Chantratita N
    Int J Antimicrob Agents; 2015 May; 45(5):557-9. PubMed ID: 25758020
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam.
    Nhung PH; Van VH; Anh NQ; Phuong DM
    J Glob Antimicrob Resist; 2019 Sep; 18():34-36. PubMed ID: 30685463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.